INTERACTION MECHANISMS OF NOVEL ANTIVIRAL PEPTIDES AGAINST N1 SUBTYPE NEURAMINIDASE: A COMPUTATIONAL EXPLORATION

被引:0
作者
Wu, F. [1 ,2 ]
Yang, Z. [1 ,2 ]
Yin, S. [3 ]
Song, C. [4 ]
Yuan, X. [5 ]
机构
[1] Jiamusi Univ, Sch Basic Med Sci, Jiamusi 154007, Peoples R China
[2] Northeast Forestry Univ, Minist Educ, Engn Res Ctr Forest Biopreparat, Harbin 150040, Peoples R China
[3] Cent Hosp Jiamusi City, Jiamusi 154007, Peoples R China
[4] Heilongjiang Nursing Coll, Harbin 150086, Peoples R China
[5] Jinan Univ, Inst Biomed, Guangzhou 510632, Guangdong, Peoples R China
关键词
Neuraminidase; Antiviral peptides; Interaction mechanisms; Docking; Molecular dynamics; AVIAN INFLUENZA NEURAMINIDASE; DRUG-RESISTANCE; VIRUS; INHIBITORS; BINDING; DESIGN; SIMULATIONS; SIALIDASE; 150-LOOP; SUGGESTS;
D O I
暂无
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
In light of the current pandemic threat and the emergence of drug resistances, the development of next-generation anti-influenza agents must be a high priority, with many efforts to bind with the 150-cavity of N1 subtype neuraminidase (NA). In this work, docking and explicit solvent molecular dynamics simulations were combined to study the interactions between N1 subtype NA and novel inhibitory peptides EISYIHAEAYRRGELK, YIHAEAYRRG and HAEAYR. It was found that 16-mer peptide EISYIHAEAYRRGELK has the binding specificity to N1 subtype NA and the capability to lock the 150-cavity. The binding-site residues Asp198, Glu227 and Glu229 play important roles during the binding process. Compared with the 16-mer peptide, YIHAEAYRRG and HAEAYR even tightly coordinated to the 150-cavity, especially of the latter. The total interaction energies (E-total) of them with N1 subtype NA were calculated to be -578.21, -442.21 and -358.80 kcal mol(-1), respectively. Further energetic and geometric analyses revealed that the portion of Tyr-Arg in peptides is more helpful for maintaining favorable contacts with residues around 150-cavity and is of great importance in the scaffold modification. We hope that the results will be helpful for designing novel anti-influenza drugs.
引用
收藏
页码:975 / 985
页数:11
相关论文
共 27 条
[1]   Influenza neuraminidase [J].
Air, Gillian M. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2012, 6 (04) :245-256
[2]   Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design [J].
Amaro, Rommie E. ;
Minh, David D. L. ;
Cheng, Lily S. ;
Lindstrom, William M., Jr. ;
Olson, Arthur J. ;
Lin, Jung-Hsin ;
Li, Wilfred W. ;
McCammon, J. Andrew .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (25) :7764-+
[3]   Mechanism of 150-cavity formation in influenza neuraminidase [J].
Amaro, Rommie E. ;
Swift, Robert V. ;
Votapka, Lane ;
Li, Wilfred W. ;
Walker, Ross C. ;
Bush, Robin M. .
NATURE COMMUNICATIONS, 2011, 2
[4]   Characterizing Loop Dynamics and Ligand Recognition in Human- and Avian-Type Influenza Neuraminidases via Generalized Born Molecular Dynamics and End-Point Free Energy Calculations [J].
Amaro, Rommie E. ;
Cheng, Xiaolin ;
Ivanov, Ivaylo ;
Xu, Dong ;
McCammon, J. Andrew .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (13) :4702-4709
[5]   Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models [J].
Bjelkmar, Par ;
Larsson, Per ;
Cuendet, Michel A. ;
Hess, Berk ;
Lindahl, Erik .
JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2010, 6 (02) :459-466
[6]   CHARMM: The Biomolecular Simulation Program [J].
Brooks, B. R. ;
Brooks, C. L., III ;
Mackerell, A. D., Jr. ;
Nilsson, L. ;
Petrella, R. J. ;
Roux, B. ;
Won, Y. ;
Archontis, G. ;
Bartels, C. ;
Boresch, S. ;
Caflisch, A. ;
Caves, L. ;
Cui, Q. ;
Dinner, A. R. ;
Feig, M. ;
Fischer, S. ;
Gao, J. ;
Hodoscek, M. ;
Im, W. ;
Kuczera, K. ;
Lazaridis, T. ;
Ma, J. ;
Ovchinnikov, V. ;
Paci, E. ;
Pastor, R. W. ;
Post, C. B. ;
Pu, J. Z. ;
Schaefer, M. ;
Tidor, B. ;
Venable, R. M. ;
Woodcock, H. L. ;
Wu, X. ;
Yang, W. ;
York, D. M. ;
Karplus, M. .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2009, 30 (10) :1545-1614
[7]   Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase [J].
Cheng, Lily S. ;
Amaro, Romanic E. ;
Xu, Dong ;
Li, Wilfred W. ;
Arzberger, Peter W. ;
McCammon, J. Andrew .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3878-3894
[8]   Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants [J].
Collins, Patrick J. ;
Haire, Lesley F. ;
Lin, Yi Pu ;
Liu, Junfeng ;
Russell, Rupert J. ;
Walker, Philip A. ;
Skehel, John J. ;
Martin, Stephen R. ;
Hay, Alan J. ;
Gamblin, Steven J. .
NATURE, 2008, 453 (7199) :1258-U61
[9]   New Antivirals and Drug Resistance [J].
Colman, Peter M. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2009, 78 :95-118
[10]   Structures of influenza A proteins and insights into antiviral drug targets [J].
Das, Kalyan ;
Aramini, James M. ;
Ma, Li-Chung ;
Krug, Robert M. ;
Arnold, Eddy .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (05) :530-538